MorphoSys AG | Key People and Executives
George S. Golumbeski
Member-Supervisory Board
Michael Brosnan
Member-Supervisory Board
Marc Cluzel
Chairman-Supervisory Board
Krisja Vermeylen
Independent Member-Supervisory Board
Wendy S. Johnson
Independent Member-Supervisory Board
Frank M. Morich
Deputy Chairman-Supervisory Board
Simon E. Moroney
Chief Executive Officer
Jens Holstein
Chief Financial Officer
Markus Enzelberger
Chief Scientific Officer
Steffen Pohlenz
Head-Information Technology
Günter Wellnhofer
Head-Technical Operations
Barbara Krebs-Pohl
Head-Business Development & Portfolio Management
Malte Peters
Chief Development Officer
Martin Clark
Head-Purchasing & Logistics
Harald Watzka
Head-Alliance Management
Ralf Ostendorp
Head-Protein Sciences & CMC
Armin Weidmann
Head-Compliance & Quality Assurance
Sascha Alilovic
Head-Corporate Finance & Corporate Development
Charlotte Lohmann
General Counsel
George S. Golumbeski
Member-Supervisory Board
Michael Brosnan
Member-Supervisory Board
Lara Smith-Weber
Head-Controlling & Corporate Finance
Klaus de Wall
Head-Accounting & Tax
Anke Linnartz
Head-Corporate Communications & IR
Silvia Dermietzel
Head-Human Resources
Gabriele Elbl
Head-Regulatory Affairs
Marc Cluzel
Chairman-Supervisory Board
Krisja Vermeylen
Independent Member-Supervisory Board
Wendy S. Johnson
Independent Member-Supervisory Board
Frank M. Morich
Deputy Chairman-Supervisory Board
| Address |
Semmelweisstraße 7
Planegg Bayern (Bavaria) 82152
Germany
|
|
Employees
|
- |
| Website |
http://www.morphosys.de |
| Updated |
07/08/2019 |
| MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments. The Proprietary Development segment combines proprietary research and development of therapeutic compounds. |
